Table 5.

Cumulative rank probabilities (in parenthesis) and the surface under cumulative ranking curve (SUCRA)

Rank	Placebo	Sitagliptin+sulfonylurea	Sitagliptin+exenatide	Linagliptin+sulfonylurea	Saxagliptin+sulfonylurea	Vildagliptin+sulfonylurea	Sitagliptin+pioglitazone	NPH+sulfonylurea
1	0.000 (0.000)	0.190 (0.190)	0.010 (0.010)	0.105 (0.105)	0.059 (0.059)	0.480 (0.480)	0.098 (0.098)	0.058 (0.098)
2	0.000 (0.000)	0.365 (0.555)	0.028 (0.037)	0.111 (0.216)	0.076 (0.135)	0.257 (0.737)	0.118 (0.216)	0.046 (0.216)
3	0.004 (0.004)	0.210 (0.764)	0.041 (0.078)	0.233 (0.449)	0.121 (0.256)	0.126 (0.863)	0.208 (0.424)	0.058 (0.424)
4	0.015 (0.019)	0.126 (0.890)	0.064 (0.142)	0.241 (0.689)	0.180 (0.436)	0.071 (0.934)	0.221 (0.646)	0.082 (0.646)
5	0.061 (0.080)	0.064 (0.954)	0.120 (0.262)	0.149 (0.838)	0.286 (0.722)	0.036 (0.970)	0.170 (0.816)	0.116 (0.816)
6	0.185 (0.264)	0.029 (0.983)	0.289 (0.551)	0.075 (0.912)	0.133 (0.854)	0.017 (0.987)	0.086 (0.901)	0.187 (0.901)
7	0.287 (0.551)	0.013 (0.996)	0.337 (0.888)	0.050 (0.962)	0.083 (0.938)	0.010 (0.996)	0.058 (0.958)	0.164 (0.958)
8	0.449 (1.000)	0.004 (1.000)	0.112 (1.000)	0.038 (1.000)	0.063 (1.000)	0.004 (1.000)	0.042 (1.000)	0.289 (1.000)
SUCRA	13.12%	76.16%	28.12%	59.59%	48.54%	85.24%	57.99%	31.22%